Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer.
about
Role of exosomes/microvesicles in the nervous system and use in emerging therapiesRecent Developments of Liposomes as Nanocarriers for Theranostic Applications.Mitochondrion: A Promising Target for Nanoparticle-Based Vaccine Delivery Systems.Recent insights into the biological activities and drug delivery systems of tanshinonesCancer nanotheranostics: improving imaging and therapy by targeted delivery across biological barriers.Gold nanoparticles for photoacoustic imagingQuantum dots as a platform for nanoparticle drug delivery vehicle designRecent progress in the development of polysaccharide conjugates of docetaxel and paclitaxelGold nanoparticles for cancer radiotherapy: a reviewNanotechnology-Based Drug Delivery Systems for Melanoma Antitumoral Therapy: A ReviewIn vivo biocompatibility, clearance, and biodistribution of albumin vehicles for pulmonary drug deliveryNanomedicine and cancer immunotherapy: focus on indoleamine 2,3-dioxygenase inhibitorsUltrasound-enhanced drug delivery for cancerRole of Physicochemical Properties in Nanoparticle ToxicityFormation and size distribution of self-assembled vesicles.Triggered drug release from superhydrophobic meshes using high-intensity focused ultrasound.Imaging and drug delivery using theranostic nanoparticlesIntegration of biosensors and drug delivery technologies for early detection and chronic management of illnessCharacterization of 9-nitrocamptothecin liposomes: anticancer properties and mechanisms on hepatocellular carcinoma in vitro and in vivo.Co-delivery of 10-hydroxycamptothecin with doxorubicin conjugated prodrugs for enhanced anticancer efficacy.Encapsulation of acetylshikonin by polyamidoamine dendrimers for preparing prominent nanoparticles.In vitro 3D model and miRNA drug delivery to target calcific aortic valve disease.Tumor-Related Exosomes Contribute to Tumor-Promoting Microenvironment: An Immunological Perspective.Antitumor effect of iRGD-modified liposomes containing conjugated linoleic acid-paclitaxel (CLA-PTX) on B16-F10 melanoma.Use of Nanotechnology to Develop Multi-Drug Inhibitors For Cancer TherapyTargeted Nanodelivery of Drugs and DiagnosticsIncreased vascular delivery and efficacy of chemotherapy after inhibition of platelet-derived growth factor-BPreparation, characterization, and optimization of primaquine-loaded solid lipid nanoparticlesCancer research by means of tissue engineering--is there a rationale?Nanoparticles of esterified polymalic acid for controlled anticancer drug release.Bioengineering strategies for designing targeted cancer therapiesAS1411 aptamer tagged PLGA-lecithin-PEG nanoparticles for tumor cell targeting and drug delivery.The application of exosomes as a nanoscale cancer vaccine.Shining light on nanotechnology to help repair and regeneration.(99m)Tc-labeled therapeutic inhaled amikacin loaded liposomes.NANOMATERIALS FOR PROTEIN MEDIATED THERAPY AND DELIVERY.Statistical fluctuation in zeta potential distribution of nanoliposomes measured by on-chip microcapillary electrophoresis.Nanocarrier mediated delivery of siRNA/miRNA in combination with chemotherapeutic agents for cancer therapy: current progress and advances.Nucleic acid aptamer-guided cancer therapeutics and diagnostics: the next generation of cancer medicine(99m)Tc-labeled porphyrin-lipid nanovesicles.
P2860
Q21129255-B03388B1-282A-4382-9AE5-A7D6C6C98F95Q26744835-1C99237F-3A9B-422A-A655-284A9FCB0A1AQ26748776-F4429468-2240-4557-91C7-A9B25DC137BDQ26770498-636B9320-AB8A-4E1B-897B-B8F9A59BFB22Q26830028-694EC2C1-AAAC-4620-A820-8121850DFFB6Q26858831-A247CA68-E4FF-4AAE-9161-957009A935CCQ26996556-7417F866-C46A-4418-BA8B-72374DB8DF8DQ27010654-10BAA93A-9E72-4CD9-B067-C484C12FEF39Q28066413-FA0242A6-B37E-473C-8F75-EF6BF5BDADF7Q28394719-AEDFCA71-9963-46A0-8F8C-A3F86DC00828Q28396006-DFAA7113-9B80-4DFF-A80A-B923FAFB54AFQ28818166-97605C59-3A83-4483-B38E-5BE097BCD0D2Q29035807-938246FC-8309-482A-BEC8-0E09CBEF367FQ29248830-D1F24389-0CA6-4A92-A7CB-11FB1C9762F1Q30360381-5637A74C-E31C-4FD4-AAC7-143D62686092Q30431665-70005EDE-7871-492D-9092-865559461335Q30449480-CFE0E3C6-0349-421F-B7C7-A1AE6895E53DQ30451853-82837265-E592-4148-91B2-3D10993BBB8EQ30475089-9A7199DC-EA12-489E-BD1E-B43B876192BDQ30590874-FEC6E967-A1C2-4866-BC5A-92898BB9B4A0Q30739130-249B097D-FA72-4975-9F15-C80C666B0ECDQ33765102-8F41D4CD-CF48-4891-A0AA-4D2A67EB1F71Q33795061-596F511B-9D49-4276-ABBD-2F07226D4C75Q33830347-20CC1597-0BAF-45A6-8708-A0055CA54135Q33859472-2902D752-96BF-4D45-89D9-8C1FBFF409C6Q33900258-1D273C50-70B7-4D25-B142-D222CF4A6984Q33922852-AF724182-F5BA-4839-85C2-47CE338932A1Q34065947-751A67CF-3DB4-495D-B204-C35040B4A666Q34154747-824F2BAB-13F0-4396-8DB4-4A299FC74D43Q34156543-B2528479-2D68-4267-9FEE-CECBDBCE917DQ34194191-950985E6-C316-4837-A20C-9B24FED6191BQ34276778-BF656F88-1A49-425F-8BD3-194CB7A851F4Q34343272-091472D9-4932-4DB7-8C62-F73DD818C0F6Q34404413-96335E67-03C8-4584-BC73-A9907E4CB4ABQ34508730-C3CFF112-1FFB-4DF5-9BBA-164F58E23C47Q34534023-F6C264F6-21BA-4308-87A3-8412B0483097Q34582858-00DDA972-2B85-4C89-A53F-E507BFADE9B3Q34622662-249E5C96-253D-40C1-B9D0-2C626B5C1560Q34698624-8EE48D24-9377-4DC9-86BA-3D852D901571Q34774033-D7245C5E-7C29-4852-A32F-5C2B351AF134
P2860
Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer.
@en
Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer.
@nl
type
label
Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer.
@en
Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer.
@nl
prefLabel
Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer.
@en
Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer.
@nl
P2093
P1476
Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer.
@en
P2093
Alexander M Seifalian
Marilena Loizidou
Yogeshkumar Malam
P304
P356
10.1016/J.TIPS.2009.08.004
P577
2009-11-01T00:00:00Z